openPR Logo
Press release

In Vitro Diagnostic IVD Reagents Market Sees Surge as Healthcare Providers Prioritize Precision Testing and Patient-Centered Care

07-28-2025 09:28 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

In Vitro Diagnostic (IVD) Reagents Market

In Vitro Diagnostic (IVD) Reagents Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global In Vitro Diagnostic (IVD) Reagents Market - (By Type (Antibodies, Purified Proteins and Peptides, Oligonucleotides, Others), By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Others), By Use (Clinical Use, Research Use, Others), By End User (IVD Manufacturers, Academic Institutes & Research Laboratories, Hospital Laboratories, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global In Vitro Diagnostic (IVD) Reagents Market is valued at USD 59.3 Bn in 2024, and it is expected to reach USD 107.2 Bn by the year 2034 , with a CAGR of 6.2% during the forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2452

In vitro diagnostic (IVD) reagents play a critical role in modern healthcare by enabling precise disease detection and supporting informed clinical decision-making. These reagents are integral to a range of diagnostic applications, including initial disease identification, continuous patient monitoring, and the customization of treatment strategies based on individual patient profiles.

The global IVD market is experiencing strong growth, largely driven by the increasing incidence of both acute and chronic conditions such as diabetes, cancer, cardiovascular diseases, and tuberculosis. Additionally, the rising prevalence of infectious diseases, respiratory disorders, and gastrointestinal illnesses has significantly heightened the demand for advanced diagnostic technologies, further accelerating market expansion.

Moreover, growing investment in research and development aimed at producing cost-effective, high-performance diagnostic solutions is expected to create substantial growth opportunities over the forecast period. However, the market continues to face challenges, particularly due to the high capital expenditure required for diagnostic equipment and the associated maintenance costs, which may limit widespread adoption across certain healthcare settings.

List of Prominent Players in the In Vitro Diagnostic (IVD) Reagents Market:
• Thermo Fisher Scientific Inc
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc
• Agilent Technologies, Inc.
• QIAGEN N.V.
• Merck KGaA
• Beckman Coulter, Inc
• Hologic, Inc
• Abcam Ltd
• Bio-Techne Corp
• InBios International, Inc.
• SDIX, LLC
• RayBiotech, Inc.
• Sino Biological Inc.
• Other Market Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics
Drivers:
The in vitro diagnostic (IVD) reagents market is experiencing significant growth, driven by several key factors that highlight its essential role in modern healthcare. A primary contributor to this expansion is the rising global prevalence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and infectious ailments including hepatitis and HIV.

IVD reagents are fundamental to the early diagnosis, clinical evaluation, and therapeutic monitoring of these conditions, making them indispensable in delivering effective and timely patient care. Concurrently, ongoing advancements in diagnostic technologies have improved test precision and patient outcomes, further stimulating demand. With healthcare systems increasingly focused on diagnostic accuracy and efficiency, the market for IVD reagents is projected to maintain a strong upward growth trajectory.

Challenges:
Despite its growth potential, the IVD reagents market faces notable challenges. High operational costs, a global shortage of skilled healthcare professionals, and the absence of standardized diagnostic procedures-particularly in developing economies-pose significant constraints. These challenges have been intensified by the COVID-19 pandemic, which disrupted global supply chains and hindered healthcare operations.

To address these issues, industry stakeholders have adopted stringent safety protocols and restructured internal workflows to enhance system resilience. Furthermore, the integration of digital collaboration tools has become essential for maintaining client support and engagement in remote settings. These strategic shifts reflect a broader industry movement toward digital transformation to improve operational efficiency and extend market reach.

Regional Trends:
North America is expected to dominate the global IVD reagents market in terms of revenue, supported by advanced healthcare infrastructure, a strong presence of leading market players, and a high incidence of chronic health conditions such as cancer, diabetes, and cardiovascular diseases.

Meanwhile, the Asia-Pacific region is projected to experience the fastest growth, fueled by increased healthcare spending, greater availability of diagnostic services, and a rising demand for point-of-care testing. Government initiatives promoting healthcare innovation, coupled with rapid technological advancements in diagnostics, are further accelerating market development across this region.

Recent Developments:
• In April 2023, ALPCO-GeneProof and Thermo Fisher formed a partnership to expand the former's portfolio of CE-IVD molecular assays. Thermo Fisher provided a portfolio comprising 37 CE-IVD molecular diagnostic assays that were originally included in the portfolio of ALPCO-GeneProof. The assays were constructed utilizing their groundbreaking "one workflow" technology, which facilitated usability and ensured compatibility with an extensive array of qPCR instruments.
• In June 2022, Biotec CerTest and BD Jointly developed a molecular diagnostic assay for monkeypox. The collaboration involved the utilization of the BD MAXTM open system reagent suite in the assay to verify the functionality of the CerTest VIASURE Monkeypox CE/IVD molecular test on the BD MAXTM System. The assay, which was accessible to BD MAXTM users, had the potential to contribute to the advancement of knowledge regarding the worldwide dissemination of the disease.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2452

Segmentation of In Vitro Diagnostic (IVD) Reagents Market-
By Type-
• Antibodies
• Purified Proteins and Peptides
• Oligonucleotides
• Others
By Technology-
• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Others
By Use-
• Clinical Use
• Research Use
• Others
By End user-
• IVD Manufacturers
• Academic Institutes & Research Laboratories
• Hospital Laboratories
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/in-vitro-diagnostic-ivd-reagents-market/2452

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Diagnostic IVD Reagents Market Sees Surge as Healthcare Providers Prioritize Precision Testing and Patient-Centered Care here

News-ID: 4122055 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5.3% CAGR Amid Rising Awareness of PCOS and PMS
Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market to Grow at 5 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Premenstrual Syndrome (PMS) and Menstrual Health Supplements Market- (By Product Type (Combined Nutritional Supplements, Single Nutritional Supplements), By Type Indication (Perimenopause, PMS), By Formulation (Capsules/Tablets, Powder, Softgels, Other), By Sales Channel (Pharmacies/Drug Stores, Online Sales Channel, Direct Sales Channel, Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North America, Europe, and Asia-Pacific
Cell and Gene Therapy CRO Market Forecast Shows Robust Growth Across North Ameri …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy CRO Market- (By Type of Cell Therapy (CAR-NK, CAR-T, TCR-T, and Others), By Type of Genetic Modification (Ex vivo and In vivo), By Stage of Development (Discovery, Preclinical, and Clinical)), By Therapeutic Area, By End-user, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, Pall Corporation, 3M Company, Waters Corporation.
Bioseparation Systems Market Top Companies Study - GE Healthcare Life Sciences, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioseparation Systems Market- (By Type (Centrifugation Technology, Cell Disruption Technology, Chromatography Technique, Extraction Technique, Filtration Technologies and Membrane-based Bioseparation and Precipitation), Application (Food, Life Sciences, Pharmaceutical and Biopharmaceutical)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Bioseparation Systems Market is valued at US$
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc.
Medical Nutrition Market Key Players Analysis - Abbott Laboratories; Pfizer Inc. …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Medical Nutrition Market Size, Share & Trends Analysis Report By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), By Patient Type (Infants, Adults, And Geriatric Populations), Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes), End-User (Home Care Settings, Long-Term Care Facilities, And Ambulatory Surgical

All 5 Releases


More Releases for IVD

Transformative Trends Impacting the Cancer In Vitro Diagnostics (IVD) Market Lan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cancer In Vitro Diagnostics (IVD) Market Size By 2025? The market size for cancer in vitro diagnostics (IVD) has seen significant growth in the past few years. The market value, which is expected to be $13.36 billion in 2024, is projected to increase to $14.32
In Vitro Diagnostics (IVD) Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this In Vitro Diagnostics (IVD) Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing
Companion Animal IVD Market - Guiding the Path to Optimal Health: Empowering Vet …
Newark, New Castle, USA - new report, titled Companion Animal IVD Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Companion Animal IVD market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Companion Animal IVD market. The report offers an overview of
IVD Market 2021 | Detailed Report
The IVD market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The IVD report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. The IVD research report also provides insights of different regions that are contributing market growth.
Liquid Biopsy IVD Market 2021 | Detailed Report
According to Market Study Report, Liquid Biopsy IVD Market provides a comprehensive analysis of the Liquid Biopsy IVD Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Liquid Biopsy IVD Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4623688 The report provides a
Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is